litlas
ログインアカウント作成

Debu Tripathy

1996–2026 年に発表

148
論文数
21,853
被引用数
67
h 指数
138
i10 指数

被引用数

Debu Tripathy の年別被引用数1964 年: 被引用 1 件1981 年: 被引用 1 件1993 年: 被引用 1 件1996 年: 被引用 1 件1997 年: 被引用 18 件1998 年: 被引用 18 件1999 年: 被引用 59 件2000 年: 被引用 109 件2001 年: 被引用 163 件2002 年: 被引用 155 件2003 年: 被引用 156 件2004 年: 被引用 158 件2005 年: 被引用 150 件2006 年: 被引用 143 件2007 年: 被引用 147 件2008 年: 被引用 132 件2009 年: 被引用 179 件2010 年: 被引用 126 件2011 年: 被引用 93 件2012 年: 被引用 106 件2013 年: 被引用 102 件2014 年: 被引用 90 件2015 年: 被引用 94 件2016 年: 被引用 88 件2017 年: 被引用 91 件2018 年: 被引用 132 件2019 年: 被引用 480 件2020 年: 被引用 703 件2021 年: 被引用 740 件2022 年: 被引用 640 件2023 年: 被引用 620 件2024 年: 被引用 904 件2025 年: 被引用 549 件2026 年: 被引用 22 件1965〜1980 年は被引用が無いため表示していません1982〜1992 年は被引用が無いため表示していません1994〜1995 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,692 件、この内訳の 28.4%中国: 引用元論文 1,004 件、この内訳の 10.6%イタリア: 引用元論文 548 件、この内訳の 5.8%イギリス: 引用元論文 497 件、この内訳の 5.2%ドイツ: 引用元論文 459 件、この内訳の 4.8%カナダ: 引用元論文 363 件、この内訳の 3.8%スペイン: 引用元論文 337 件、この内訳の 3.6%フランス: 引用元論文 334 件、この内訳の 3.5%オーストラリア: 引用元論文 253 件、この内訳の 2.7%スイス: 引用元論文 207 件、この内訳の 2.2%日本: 引用元論文 203 件、この内訳の 2.1%オランダ: 引用元論文 189 件、この内訳の 2%
0%28.4%その他 25.3%

機関

分野

  • Medicine66.6%
  • Biochemistry, Genetics and Molecular Biology25.4%
  • Immunology and Microbiology1.8%
  • Materials Science1.4%
  • Computer Science1.2%
  • Engineering0.8%
  • その他2.8%

トピック

  • HER2/EGFR in Cancer Research9.6%
  • Advanced Breast Cancer Therapies6.4%
  • Breast Cancer Treatment Studies5.5%
  • Monoclonal and Polyclonal Antibodies Research4.4%
  • Cancer Genomics and Diagnostics3.1%
  • Cancer-related Molecular Pathways2.9%
  • その他68.1%

共著者

全論文

検索で開く
  1. Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

    著者: Mark Jesus M. Magbanua, Lamorna Brown Swigart, H.-T. Wu, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Aung Soe Tin, Raheleh Salari, Svetlana Shchegrova, H. Pawar, Amy L. Delson, Angela DeMichele, M.C. Liu, A. Jo Chien, Debu Tripathy, Smita Asare, C-HJ Lin, Paul R. Billings, Alexey Aleshin, Himanshu Sethi, Maggie C. Louie, Bernhard Zimmermann, Laura J. Esserman, Laura van ‘t Veer - Annals of Oncology 2020 被引用: 438

  2. Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

    著者: Debu Tripathy, Seock‐Ah Im, Marco Colleoni, Fábio Franke, Aditya Bardia, Nadia Harbeck, Sara A. Hurvitz, Louis W.C. Chow, Joohyuk Sohn, Keun Seok Lee, Saúl Campos-Gómez, Rafael Villanueva-Vázquez, Kyung Hae Jung, Govind Babu, Paul Wheatley‐Price, Michelino De Laurentiis, Young‐Hyuck Im, Sherko Küemmel, Nagi S. El-Saghir, Mei-Ching Liu, Gary P. Carlson, Gareth Hughes, Iván Díaz-Padilla, Caroline Germa, Samit Hirawat, Yen‐Shen Lu - The Lancet Oncology 2018 被引用: 1,011

  3. Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer

    著者: Seock‐Ah Im, Yen‐Shen Lu, Aditya Bardia, Nadia Harbeck, Marco Colleoni, Fábio Franke, Louis W.C. Chow, Joohyuk Sohn, Keun-Seok Lee, Saúl Campos-Gómez, Rafael Villanueva-Vázquez, Kyung-Hae Jung, Arunava Chakravartty, Gareth Hughes, Ioannis Gounaris, Karen Rodriguez-Lorenc, Tetiana Taran, Sara A. Hurvitz, Debu Tripathy - New England Journal of Medicine 2019 被引用: 1,021

  4. Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

    著者: Mark Jesus M. Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova, Gillian L. Hirst, Christina Yau, Denise M. Wolf, Wen Li, Amy L. Delson, Smita Asare, Minetta C. Liu, Kathy S. Albain, A. Jo Chien, Andres Forero‐Torres, Claudine Isaacs, Rita Nanda, Debu Tripathy, Angel Rodriguez, Himanshu Sethi, Alexey Aleshin, Matthew Rabinowitz, Jane Perlmutter, W. Fraser Symmans, Douglas Yee, Nola M. Hylton, Laura J. Esserman, Angela DeMichele, Hope S. Rugo, Laura van ‘t Veer - Cancer Cell 2023 被引用: 171

  5. Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2− Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial

    著者: Yen-Shen Lu, Seock-Ah Im, Marco Colleoni, Fabio Franke, Aditya Bardia, Fatima Cardoso, Nadia Harbeck, Sara Hurvitz, Louis Chow, Joohyuk Sohn, Keun Seok Lee, Saul Campos-Gomez, Rafael Villanueva Vazquez, Kyung Hae Jung, K. Govind Babu, Paul Wheatley-Price, Michelino De Laurentiis, Young-Hyuck Im, Sherko Kuemmel, Nagi El-Saghir, Ruth O'Regan, Claudia Gasch, Nadia Solovieff, Craig Wang, Yongyu Wang, Arunava Chakravartty, Yan Ji, Debu Tripathy - Clinical Cancer Research 2021 被引用: 263

  6. Clinical practice guidelines on the evidence‐based use of integrative therapies during and after breast cancer treatment

    著者: Heather Greenlee, Melissa J. DuPont‐Reyes, Lynda G. Balneaves, Linda E. Carlson, Misha Cohen, Gary Deng, Jillian A. Johnson, Matthew P. Mumber, Dugald Seely, Suzanna M. Zick, Lindsay Boyce, Debu Tripathy - CA A Cancer Journal for Clinicians 2017 被引用: 768

  7. Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial

    著者: Christina M. Dieli‐Conwright, Kerry S. Courneya, Wendy Demark‐Wahnefried, Nathalie Sami, Kyuwan Lee, Thomas A. Buchanan, Darcy Spicer, Debu Tripathy, Leslie Bernstein, Joanne Mortimer - Journal of Clinical Oncology 2018 被引用: 354

  8. Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial

    著者: Christina M. Dieli‐Conwright, Kerry S. Courneya, Wendy Demark‐Wahnefried, Nathalie Sami, Kyuwan Lee, Frank C. Sweeney, Christina F. Stewart, Thomas A. Buchanan, Darcy Spicer, Debu Tripathy, Leslie Bernstein, Joanne Mortimer - Breast Cancer Research 2018 被引用: 320

  9. Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials

    著者: Fabrice André, Faye Su, Nadia Solovieff, Gabriel N. Hortobágyi, S. Chia, Patrick Neven, Aditya Bardia, Debu Tripathy, Y.-S. Lu, Agnes Lteif, T Taran, Naveen Babbar, DJ Slamon, Carlos L. Arteaga - Annals of Oncology 2023 被引用: 90

  10. CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers

    著者: Smruthi Vijayaraghavan, Cansu Karakaş, Iman Doostan, Xian Chen, Tuyen Bui, Min Yi, Akshara Singareeka Raghavendra, Yang Zhao, Sami I. Bashour, Nuhad K. Ibrahim, Meghan Karuturi, Jing Wang, Jeffrey D. Winkler, Ravi K. Amaravadi, Kelly K. Hunt, Debu Tripathy, Khandan Keyomarsi - Nature Communications 2017 被引用: 293

  11. Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer

    著者: Kurt W. Evans, Erkan Yuca, Stephen M. Scott, Ming Zhao, Natalia Paez Arango, Christian X. Cruz Pico, Turçin Saridogan, Maryam Shariati, Caleb A. Class, Christopher A. Bristow, Christopher P. Vellano, Xiaofeng Zheng, Ana M. González-Angulo, Xiaoping Su, Coya Tapia, Ken Chen, Argun Akçakanat, Bora Lim, Debu Tripathy, Timothy A. Yap, Maria Emilia Di Francesco, Giulio Draetta, Philip Jones, Timothy P. Heffernan, Joseph R. Marszalek, Funda Meric‐Bernstam - Cancer Research 2021 被引用: 157

  12. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer

    著者: Charles L. Vogel, Melody Cobleigh, Debu Tripathy, John Gutheil, Lyndsay N. Harris, Louis Fehrenbacher, Dennis J. Slamon, Maureen Murphy, William Novotny, Michael Burchmore, Steven Shak, Stanford J. Stewart, Michael F. Press - Journal of Clinical Oncology 2002 被引用: 1,859

  13. Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

    著者: Eve T. Rodler, Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders, Lori J. Goldstein, Debu Tripathy, Ursa Brown‐Glaberman, Thu-Tam Huynh, Christopher S Szyarto, Andrew K. Godwin, Harsh B. Pathak, Elizabeth M. Swisher, Marc R. Radke, Kirsten M. Timms, Danika L. Lew, Jieling Miao, Lajos Pusztai, Daniel F. Hayes, Gabriel N. Hortobágyi - The Lancet Oncology 2023 被引用: 98

  14. MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

    著者: Chengyue Wu, Angela M. Jarrett, Zijian Zhou, Nabil Elshafeey, Beatriz E. Adrada, Rosalind P. Candelaria, Rania M. Mohamed, Medine Böge, Lei Huo, Jason B. White, Debu Tripathy, Vicente Valero, Jennifer K. Litton, Clinton Yam, Jong Bum Son, Jingfei Ma, Gaiane M. Rauch, Thomas E. Yankeelov - Cancer Research 2022 被引用: 73

  15. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI

    著者: Zijian Zhou, Beatriz E. Adrada, Rosalind P. Candelaria, Nabil Elshafeey, Medine Böge, Rania M. Mohamed, Sanaz Pashapoor, Jia Sun, Zhan Xu, Bikash Panthi, Jong Bum Son, Mary S. Guirguis, Miral Patel, Gary J. Whitman, Tanya W. Moseley, Marion E. Scoggins, Jason B. White, Jennifer K. Litton, Vicente Valero, Kelly K. Hunt, Debu Tripathy, Wei Yang, Peng Wei, Clinton Yam, Mark D. Pagel, Gaiane M. Rauch, Jingfei Ma - Scientific Reports 2023 被引用: 43

  16. Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

    著者: Juliana Navarro-Yepes, Nicole M. Kettner, Xiayu Rao, Cassandra Santaella Bishop, Tuyen Bui, Hannah F. Wingate, Akshara Singareeka Raghavendra, Yan Wang, Jing Wang, Ayşegül A. Şahin, Funda Meric‐Bernstam, Kelly K. Hunt, Senthil Damodaran, Debu Tripathy, Khandan Keyomarsi - Cancer Research 2023 被引用: 52

  17. Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

    著者: Nicole M. Kettner, Smruthi Vijayaraghavan, Merih Güray Durak, Tuyen Bui, Mehrnoosh Kohansal, Min Jin Ha, Bin Liu, Xiayu Rao, Jing Wang, Min Yi, Jason P.W. Carey, Xian Chen, T. Kris Eckols, Akshara Singareeka Raghavendra, Nuhad K. Ibrahim, Meghan Karuturi, Stephanie S. Watowich, Ayşegül A. Şahin, David J. Tweardy, Kelly K. Hunt, Debu Tripathy, Khandan Keyomarsi - Clinical Cancer Research 2019 被引用: 133

  18. Ribociclib (LEE011): Mechanism of Action and Clinical Impact of This Selective Cyclin-Dependent Kinase 4/6 Inhibitor in Various Solid Tumors

    著者: Debu Tripathy, Aditya Bardia, William R. Sellers - Clinical Cancer Research 2017 被引用: 242

  19. Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer

    著者: Howard A. Burris, Arlene Chan, Aditya Bardia, J. Thaddeus Beck, Joohyuk Sohn, Patrick Neven, Debu Tripathy, Seock‐Ah Im, Stephen Chia, Francisco J. Esteva, Lowell L. Hart, Juan Pablo Zarate, Antonia Ridolfi, Karen Rodriguez Lorenc, Denise A. Yardley - British Journal of Cancer 2021 被引用: 90

  20. EGFR is a master switch between immunosuppressive and immunoactive tumor microenvironment in inflammatory breast cancer

    著者: Xiaoping Wang, Takashi Semba, Ganiraju C. Manyam, Jing Wang, Shan Shao, François Bertucci, Pascal Finetti, Savitri Krishnamurthy, Lan Thi Phi, Troy Pearson, Steven Van Laere, Jared K. Burks, Evan N. Cohen, James M. Reuben, Fei Yang, Min Hu, Nicholas E. Navin, Van Ngu Trinh, Toshiaki Iwase, Harsh Vardhan Batra, Yichao Shen, Xiang H.-F. Zhang, Debu Tripathy, Naoto T. Ueno - Science Advances 2022 被引用: 64

  21. Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease

    著者: Melody Cobleigh, Charles L. Vogel, Debu Tripathy, Nicholas J. Robert, Suzy Scholl, Louis Fehrenbacher, Janet Wolter, Virginia Paton, Steven Shak, Gracie Lieberman, Dennis J. Slamon - Journal of Clinical Oncology 1999 被引用: 2,790

  22. Central Nervous System Metastases in Patients with HER2-Positive Metastatic Breast Cancer: Incidence, Treatment, and Survival in Patients from registHER

    著者: Adam Brufsky, Musa Mayer, Hope S. Rugo, Peter A. Kaufman, Elizabeth Tan-Chiu, Debu Tripathy, Iulia Cristina Tudor, Lisa I. Wang, Melissa Brammer, Mona Shing, Marianne Ulcickas Yood, Denise A. Yardley - Clinical Cancer Research 2011 被引用: 400

  23. Management of Fatigue in Adult Survivors of Cancer: ASCO–Society for Integrative Oncology Guideline Update

    著者: Julienne E. Bower, Christina Lacchetti, Yesne Alici, Debra L. Barton, Deborah Watkins Bruner, Beverly Canin, Carmelita P. Escalante, Patricia A. Ganz, Sheila N. Garland, Shilpi Gupta, Heather Jim, Jennifer A. Ligibel, Kah Poh Loh, Luke J. Peppone, Debu Tripathy, Sriram Yennu, Suzanna M. Zick, Karen M. Mustian - Journal of Clinical Oncology 2024 被引用: 217

  24. Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

    著者: The I-SPY 1 TRIAL Investigators, Laura J. Esserman, Donald A. Berry, Maggie C.U. Cheang, Christina Yau, Charles M. Perou, Lisa A. Carey, Angela DeMichele, Joe W. Gray, Kathleen Conway‐Dorsey, Marc E. Lenburg, Meredith Buxton, Sarah Davis, Laura J. van’t Veer, Clifford A. Hudis, Koei Chin, Denise M. Wolf, Helen Krontiras, Leslie L. Montgomery, Debu Tripathy, Constance D. Lehman, Minetta C. Liu, Olufunmilayo I. Olopade, Hope S. Rugo, John T. Carpenter, Chad Livasy, Lynn G. Dressler, David C. Chhieng, Baljit Singh, Carolyn Mies, Joseph T. Rabban, Yunni-Yi Chen, Dilip D. Giri, Alfred Au, Nola M. Hylton - Breast Cancer Research and Treatment 2011 被引用: 376